[ Price : $8.95]
FDA grants breakthrough therapy designations to Alzheimers drugs being developed by Lilly and Eisai/ Biogen.[ Price : $8.95]
FDA issues a notice of violation to the Roger Williams Medical Center Oncology Pharmacy Clinic relating to deficiencies in the pre...[ Price : $8.95]
FDA approves an Oticon Medical PMA for the companys Neuro System, a cochlear implant for treating individuals 18 years or older wi...[ Price : $8.95]
Retired FDA psychiatry products director Thomas Laughren joins Cybin as a clinical advisory board member.[ Price : $8.95]
FDA warns Fresh Nutrition it is selling misbranded and unapproved new human and animal drugs.[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Daiichi Sankyos Turalio (pe...[ Price : $8.95]
FDA releases an FDA-483 with two observations from an inspection at Venus Concept.[ Price : $8.95]
New FDA-posted review documents provide more insight into how FDA reconciled using the accelerated approval pathway for Biogens Al...